Treatment.com AI Engages Market Maker
Rhea-AI Summary
Treatment.com AI (OTC: TREIF) has engaged Independent Trading Group (ITG) as its market maker starting July 29, 2025. The agreement aims to maintain reasonable market conditions and enhance the liquidity of Treatment's common shares across all trading venues.
Under the agreement terms, ITG will receive CAD $5,500 monthly compensation, with an initial one-month term that automatically renews unless terminated with 30 days' notice. No performance factors, shares, or options are included in the compensation package. ITG, established in 1992, is a Toronto-based CIRO dealer-member specializing in market making and liquidity provision services.
Positive
- Potential improvement in stock liquidity through professional market making services
- Partnership with established market maker (ITG) with over 30 years of experience
Negative
- Additional monthly expense of CAD $5,500 for market making services
News Market Reaction – TREIF
On the day this news was published, TREIF declined 1.91%, reflecting a mild negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Vancouver, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) -- Treatment.com AI Inc. (the “Company” or “Treatment”) (CSE: TRUE; OTC: TREIF; 939: FRA) has engaged the services of Independent Trading Group ("ITG") pursuant to an agreement dated and starting on July 29, 2025 (the “Agreement”) to provide market-making services in accordance with Canadian Securities Exchange (“CSE”) policies. ITG will trade shares of the Company on the CSE and all other trading venues with the objective of maintaining a reasonable market and improving the liquidity of the Company's common shares.
Under the terms of the Agreement, ITG will receive compensation of CAD
Independent Trading Group (ITG) Inc. is a Toronto based CIRO dealer-member that specializes in market making, liquidity provision, agency execution, ultra-low latency connectivity, and bespoke algorithmic trading solutions. Established in 1992, with a focus on market structure, execution and trading, ITG has leveraged its own proprietary technology to deliver high quality liquidity provision and execution services to a broad array of public issuers and institutional investors.
About Treatment.com AI Inc.
Treatment.com AI is a company utilizing AI and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, Treatment has built a comprehensive, personalized healthcare AI engine, the Global Library of Medicine (GLM). With more than ~10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals, as well as providing recommended tests (physical and lab), x-rays, and billing codes. The GLM helps healthcare professionals (doctor, nurse or pharmacist) reduce their administrative burden; create more time for needed face to face patient appointments and enables greater consistency in quality of patient support. Treatment’s GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. To learn more about Treatment’s products and services: www.treatment.com or email: info@treatment.com
FOR ADDITIONAL INFORMATION, CONTACT:
Dr. Essam Hamza, CEO
For media inquiries, contact: media@treatment.com
Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955
Cautionary Statements
This news release contains forward-looking statements relating to the future operations of Treatment and other statements that are not historical facts. Forward-looking statements are often identified by terms such as "will", "may", "should", "anticipate", "expects" and similar expressions. All statements other than statements of historical fact, included in this release, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from Treatment's expectations include other risks detailed from time to time in the filings made by Treatment with securities regulators.
The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of Treatment. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date of this news release and Treatment will only update or revise publicly the included forward-looking statements as expressly required by Canadian securities law.
FAQ
What is the purpose of Treatment.com AI (TREIF) engaging a market maker?
How much will Treatment.com AI (TREIF) pay ITG for market making services?
What is the duration of Treatment.com AI's market making agreement with ITG?
Who is Independent Trading Group (ITG) and what services do they provide?
Will ITG receive any shares or performance-based compensation from Treatment.com AI?
